The recent development of antibodies against human TK1 has enabled the determination of serum TK1 protein levels in different hematologic and solid tumors such as bladder carcinoma [16], breast carcinomas [17], and non-small cell lung cancer [18]. The gene discussed is TK1; the disease is breast carcinoma.